Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1986-3-21
|
| pubmed:abstractText |
Postmenopausal women receiving conjugated oestrogens 1.25 mg daily continuously were also given dydrogesterone either 5, 10 or 20 mg daily for the first 12 days of each calendar month. Endometrial tissue obtained on the sixth day of combined therapy in the third or subsequent treatment cycle was subjected to histological, ultrastructural and biochemical assessments. Dydrogesterone provoked secretory histological and ultrastructural changes within the endometrium in a dose-dependent manner. A daily dose of 5 mg produced sub-optimal responses but 10 and 20 mg daily produced effects similar to those observed in the secretory phase of the ovulatory cycle. Dydrogesterone 10 mg and 20 mg daily reduced epithelial DNA synthesis and nuclear oestradiol receptor levels to values within the secretory phase range. A dose-response relation was seen in the induction of oestradiol-17 beta and isocitrate dehydrogenase activities; hyperphysiological values were observed with 20 mg of dydrogesterone daily. This study has demonstrated that dydrogesterone exerts potent anti-oestrogenic and progestational effects on the human endometrium which are dose-related. The 10 and 20 mg doses induced responses equal to or greater than those observed in the secretory phase of the ovulatory cycle and both dosages can be recommended for use in combination with exogenous oestrogens in postmenopausal women: and they may also have a role in the management of anovulatory dysfunctional uterine bleeding.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
0306-5456
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
93
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
55-62
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:3002419-Cell Nucleus,
pubmed-meshheading:3002419-DNA,
pubmed-meshheading:3002419-Dose-Response Relationship, Drug,
pubmed-meshheading:3002419-Dydrogesterone,
pubmed-meshheading:3002419-Endometrial Hyperplasia,
pubmed-meshheading:3002419-Endometrium,
pubmed-meshheading:3002419-Epithelium,
pubmed-meshheading:3002419-Estrogens, Conjugated (USP),
pubmed-meshheading:3002419-Female,
pubmed-meshheading:3002419-Humans,
pubmed-meshheading:3002419-Menopause,
pubmed-meshheading:3002419-Microscopy, Electron,
pubmed-meshheading:3002419-Receptors, Estradiol
|
| pubmed:year |
1986
|
| pubmed:articleTitle |
Effects of dydrogesterone on the oestrogenized postmenopausal endometrium.
|
| pubmed:publicationType |
Journal Article
|